abstract |
The present invention is directed to new antibiotic substances denominated antibiotic GE 2270 factors A₁, A₂, A₃ and H, the addition salts thereof, the pharmaceutical compositions thereof and their use as medicaments, particularly in the treatment of infectious diseases involving microorganisms susceptible to them. |